

ImmunoScape, a biotech firm focused on the human immune system, has raised $11 million in funding. Anzu Partners led the round with participation from University of Tokyo Edge Capital and NPR Holdings.
Source: Press Release
ImmunoScape, a biotech firm focused on the human immune system, has raised $11 million in funding.
ImmunoScape, a biotech firm focused on the human immune system, has raised $11 million in funding. Anzu Partners led the round with participation from University of Tokyo Edge Capital and NPR Holdings.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination